Quark Venture

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies. The company is creating a strong pipeline of radiopharmaceuticals to target solid and hematologic malignancies. Its systematic approach to radiotherapeutic design is fueled by a toolbox of technologies and chemistries, which offers broad potential for expansion into a multitude of oncology targets. Alpha9 Theranostics was founded in 2019 and is headquartered in Vancouver, Canada.

Founded in 2013, Canary Medical specializes in developing implantable sensor technology for remote patient monitoring. Its flagship product, canturio™te, is the world's first 'smart knee' tibial extension that monitors joint performance and transmits data to the cloud autonomously.

PHEMI Systems Corporation specializes in developing a comprehensive privacy, security, governance, and data management system optimized for Microsoft Azure. Founded in 2013 and based in Vancouver, Canada, the company focuses on the healthcare sector, offering the PHEMI Data Privacy Manager. This cloud-based platform addresses the critical need for healthcare organizations to secure, manage, and control access to sensitive information while ensuring compliance with privacy regulations. Built on a privacy-by-design architecture, PHEMI’s software facilitates data sharing and integrates seamlessly with numerous data sources, as well as popular data science and business analysis tools. The platform is designed to scale according to the organization's size and offers a flexible usage-based pricing model.

Microbion Corporation is a biopharmaceutical company dedicated to developing products for treating resistant and difficult-to-treat infections. It specializes in bismuth-thiols, used to prevent microbial biofilms on medical devices and manage infectious diseases. Founded in 1982, the company is headquartered in Bozeman, Montana.